Contemporary management of postchemotherapy testis cancer.
about
Surgical controversies in the management of post-chemotherapy nonretroperitoneal residual disease in metastatic nonseminomatous germ cell tumorsRole of chemotherapy prior to orchiectomy in metastatic testicular cancer-is testis really a sanctuary site?Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?Primary Malignant Mixed Germ Cell Tumour with Squamous Cell Carcinoma of the Mandible; A Rare Entity.SEOM clinical guidelines for the management of germ cell testicular cancer (2016).Platinum-refractory germ cell tumors: an update on current treatment options and developments.Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.Growing teratoma syndromePrimary Germ Cell Tumor of Testes with Extensive Lymph Nodal and Splenic Metastases Masquerading Lymphoma on 18-F-FDG PET/CTGrowing teratoma syndrome: clinical and radiographic characteristics.External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.Improved survival in metastatic germ-cell cancer.[When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?][Importance of pathology for therapy planning of testicular germ cell tumors].Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors.Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma.Integrated Molecular Characterization of Testicular Germ Cell Tumors
P2860
Q26750585-71A0D0F5-431A-43E1-8D1D-AA73809CABA8Q26995783-FBDC1DE9-2D51-4137-ABAD-4C94A76BCDC9Q33577850-70C4F227-2398-4A83-9C0D-5751AF702435Q35918336-69872746-03E8-4589-9549-3A08A01ECBAEQ37475147-168FB345-43D8-4328-9EE5-647D3A78ECE7Q38906007-5C1653C1-EC91-416E-9076-46183F1DFE62Q38991575-FE13DB30-609D-4322-85A2-AA27DD7352A7Q39177653-F4D79CE9-769D-4D03-B639-2D0B1C6E0078Q40532423-AEDE8888-6B52-4F82-AF8B-F8839CA3A16FQ40955727-6867323E-0F71-4444-90EA-A85F27873D03Q41837065-4ADC46AC-5BD6-4C52-8D38-7FFA9C5F0BD2Q41911611-19FE4D93-7733-41CC-9C87-2102EFB3FECBQ44357902-C185D2CE-45AE-40A3-A4B8-037B1A7813B6Q46728739-5A1BD4BF-A5F5-41CF-A371-9DF9818EAF05Q47210644-F58D4B47-05AF-4CC9-A43B-ED278F774B3DQ52673854-EE04DD77-776A-4A31-B5BB-E018C56F42FCQ53055134-A5C6E82A-135F-4F32-9552-CDF91DA1E33BQ53079025-E6672C53-5823-4203-AFD8-54C7D909BF79Q55262229-F430FD1A-C031-4C8E-B4A2-65790546850BQ57261167-8236AF70-E4B5-4A9A-9F88-D5FA2C0ADF8A
P2860
Contemporary management of postchemotherapy testis cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Contemporary management of postchemotherapy testis cancer.
@en
type
label
Contemporary management of postchemotherapy testis cancer.
@en
prefLabel
Contemporary management of postchemotherapy testis cancer.
@en
P2093
P1433
P1476
Contemporary management of postchemotherapy testis cancer.
@en
P2093
Axel Heidenreich
Christian Kollmannsberger
Craig Nichols
Jan Oldenburg
Peter Albers
Susan Krege
P304
P356
10.1016/J.EURURO.2012.08.014
P407
P577
2012-08-20T00:00:00Z